You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 169 No. 19, October 26, 2009 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Research Letters
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (14)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in this journal
 Topic Collections
 •Nutritional and Metabolic Disorders
 •Nutrition/ Malnutrition
 •Prognosis/ Outcomes
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?


Vitamin D2 Treatment for Vitamin D Deficiency and Insufficiency for Up to 6 Years

Sara M. Pietras, MD; Busayo K. Obayan, BA; Mona H. Cai, BS, MPH; Michael F. Holick, PhD, MD

Arch Intern Med. 2009;169(19):1806-1808.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The worldwide prevalence of vitamin D deficiency is striking, and more than 40% of the population may be vitamin D deficient.1 Despite this, to our knowledge there are no long-term studies of the safety and efficacy of giving pharmacologic doses of vitamin D (50 000 IU of ergocalciferol [vitamin D2]) to treat and prevent vitamin D deficiency. Furthermore, there is a concern that ergocalciferol, the only pharmaceutical vitamin D available in the United States, may be less effective than cholecalciferol (vitamin D3).2 In our clinic, which specializes in metabolic bone disease, we routinely treat vitamin D deficiency (serum 25-hydroxyvitamin D [25(OH)D] levels <20 ng/mL [to convert to nanomoles per liter, multiply by 2.496]) with 50 000 IU of ergocalciferol once a week for 8 weeks.1, 3 The efficacy of this regimen has been . . . [Full Text of this Article]

Methods


Results

Comment

AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Vitamin D Supplementation
Andrew Grey, Mark J. Bolland, and Ian R. Reid
Arch Intern Med. 2010;170(6):572-573.
EXTRACT | FULL TEXT  

Vitamin D Supplementation—Reply
Sara M. Pietras and Michael F. Holick
Arch Intern Med. 2010;170(6):573.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Vitamin D Deficiency in Patients Receiving Home Parenteral Nutrition
Thomson and Duerksen
JPEN J Parenter Enteral Nutr 2011;35:499-504.
ABSTRACT | FULL TEXT  

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
Holick et al.
J. Clin. Endocrinol. Metab. 2011;96:1911-1930.
ABSTRACT | FULL TEXT  

Evaluation of Ergocalciferol or Cholecalciferol Dosing, 1,600 IU Daily or 50,000 IU Monthly in Older Adults
Binkley et al.
J. Clin. Endocrinol. Metab. 2011;96:981-988.
ABSTRACT | FULL TEXT  

Vitamin D - Let's Get Back to the Evidence Base
Reid
IBMS BoneKEy 2010;7:249-253.
FULL TEXT  

Annual High-Dose Oral Vitamin D and Falls and Fractures in Older Women: A Randomized Controlled Trial
Sanders et al.
JAMA 2010;303:1815-1822.
ABSTRACT | FULL TEXT  

Vitamin D Supplementation
Grey et al.
Arch Intern Med 2010;170:572-573.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.